Abdominal Aortic Aneurysm Endograft Labeling Changes Likely - DCRD

Updates on long-term clinical data will provide a basis for abdominal aortic aneurysm endovascular graft labeling changes, FDA suggested during a session on the devices July 9 at FDA's Circulatory System Devices Panel meeting in Gaithersburg, Maryland.